Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): A phase 3, multicentre, randomised trial

Karim Fizazi, Lance Pagliaro, Agnes Laplanche, Aude Fléchon, Josef Mardiak, Lionnel Geoffrois, Pierre Kerbrat, Christine Chevreau, Remy Delva, Frederic Rolland, Christine Theodore, Guilhem Roubaud, Gwenaëlle Gravis, Jean Christophe Eymard, Jean Pierre Malhaire, Claude Linassier, Muriel Habibian, Anne Laure Martin, Florence Journeau, Maria ReckovaChristopher Logothetis, Stephane Culine

Research output: Contribution to journal › Article › peer-review

108 Scopus citations

Fingerprint

Dive into the research topics of 'Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): A phase 3, multicentre, randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences